Colorectal hepatic metastasis: Evolving therapies.

Area of Science:

• Hepatobiliary surgery
• Surgical oncology
• Medical oncology

Background:

• Colorectal liver metastases (CLM) are a significant cause of cancer mortality.
• Past decade has seen major advancements in CLM management.
• Multidrug chemotherapy and multimodal therapies have improved patient outcomes.

Purpose of the Study:

• To review recent advancements in the surgical and oncologic management of colorectal liver metastases.
• To discuss modern chemotherapeutic regimens, adjunct therapies, and surgical aspects of liver resection for CLM.

Main Methods:

• Review of current literature on colorectal liver metastases management.
• Discussion of surgical techniques and oncologic treatment strategies.
• Synthesis of data on chemotherapy and adjunct therapies.

Main Results:

• Multidrug chemotherapy regimens have improved outcomes for CLM.
• Adjunct multimodal therapies have enhanced survival rates.
• Increased number of patients are now eligible for curative liver resection.

Conclusions:

• Significant progress has been made in managing colorectal liver metastases.
• Integrated approaches combining surgery, chemotherapy, and multimodal therapies are key.
• Further research will continue to refine treatment strategies for improved patient survival.